|
|
 |
INDIA-JAPAN-PHARMACEUTICAL-SUN-ACQUISITION-DAIICHI-RANBAXY
An Indian pedestrian walks past a Sun Pharma signboard in Mumbai on April 7, 2014. India's third-biggest drugs company Sun Pharma announced a $3.2-billion deal to buy larger domestic rival Ranbaxy from Daiichi Sankyo, ending the Japanese company's costly run as owner. The agreement would create India's largest drugs manufacturer and the fifth-biggest worldwide by sales while Ranbaxy shareholders will get a nearly 20 percent premium to the average 30-day share price. India, known as the "pharmacy to the world" because of its vast generics market, supplies medicines to more than 200 countries and is the second-largest US drugs supplier after Canada. AFP PHOTO / INDRANIL MUKHERJEE
|
|
|
|
Detalii fotografie |
| Loc: |
|
Mumbai, INDIA |
|
| Sursa: |
|
AFP / Mediafax Foto |
|
| Fotograf: |
|
Indranil MUKHERJEE |
|
| Data: |
|
7 Aprilie 2014 |
|
| Dimensiuni: |
|
3095 x 1996 (1.4 MB) |
|
|
|
|
|
|